1. Home
  2. NXPLW vs KSPI Comparison

NXPLW vs KSPI Comparison

Compare NXPLW & KSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • KSPI
  • Stock Information
  • Founded
  • NXPLW N/A
  • KSPI 2008
  • Country
  • NXPLW United States
  • KSPI Kazakhstan
  • Employees
  • NXPLW 166
  • KSPI N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • KSPI
  • Sector
  • NXPLW Telecommunications
  • KSPI
  • Exchange
  • NXPLW Nasdaq
  • KSPI Nasdaq
  • Market Cap
  • NXPLW N/A
  • KSPI N/A
  • IPO Year
  • NXPLW N/A
  • KSPI 2024
  • Fundamental
  • Price
  • NXPLW $0.23
  • KSPI $94.30
  • Analyst Decision
  • NXPLW
  • KSPI Strong Buy
  • Analyst Count
  • NXPLW 0
  • KSPI 2
  • Target Price
  • NXPLW N/A
  • KSPI $138.50
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • KSPI 314.4K
  • Earning Date
  • NXPLW 03-31-2025
  • KSPI 04-15-2025
  • Dividend Yield
  • NXPLW N/A
  • KSPI 7.76%
  • EPS Growth
  • NXPLW N/A
  • KSPI 23.97
  • EPS
  • NXPLW N/A
  • KSPI 10.35
  • Revenue
  • NXPLW $66,482,000.00
  • KSPI $4,849,581,791.00
  • Revenue This Year
  • NXPLW N/A
  • KSPI $11.49
  • Revenue Next Year
  • NXPLW N/A
  • KSPI $19.86
  • P/E Ratio
  • NXPLW N/A
  • KSPI $9.11
  • Revenue Growth
  • NXPLW 179.89
  • KSPI 33.72
  • 52 Week Low
  • NXPLW $0.25
  • KSPI $86.24
  • 52 Week High
  • NXPLW $0.26
  • KSPI $143.72
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • KSPI 37.90
  • Support Level
  • NXPLW N/A
  • KSPI $91.33
  • Resistance Level
  • NXPLW N/A
  • KSPI $98.46
  • Average True Range (ATR)
  • NXPLW 0.00
  • KSPI 2.49
  • MACD
  • NXPLW 0.00
  • KSPI -0.37
  • Stochastic Oscillator
  • NXPLW 0.00
  • KSPI 19.09

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: